Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons.
about
Drug safety evaluation of olanzapine pamoate.Post-injection delirium/sedation syndrome in patients treated with olanzapine pamoate: mechanism, incidence, and management.Olanzapine pamoate for the treatment of schizophrenia--a safety evaluation.Defining the minimal clinically important difference (MCID) of the Heinrichs-carpenter quality of life scale (QLS).Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses.
P2860
Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Treatment-completion rates wit ...... rect, exploratory comparisons.
@ast
Treatment-completion rates wit ...... rect, exploratory comparisons.
@en
type
label
Treatment-completion rates wit ...... rect, exploratory comparisons.
@ast
Treatment-completion rates wit ...... rect, exploratory comparisons.
@en
prefLabel
Treatment-completion rates wit ...... rect, exploratory comparisons.
@ast
Treatment-completion rates wit ...... rect, exploratory comparisons.
@en
P2093
P2860
P356
P1476
Treatment-completion rates wit ...... rect, exploratory comparisons.
@en
P2093
David P McDonnell
Kristina A Coleman
Peter D Feldman
William S Montgomery
P2860
P304
P356
10.2147/IJGM.S29052
P407
P577
2012-05-04T00:00:00Z